[1]
S. Aliberti, “Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement”, Multidiscip Respir Med, vol. 13, no. 1, Oct. 2018, doi: 10.4081/mrm.2018.200.